{"schema_version":"secwatch.filing_event.v1","accession":"0001179929-24-000086","form_type":"8-K","ticker":"MOH","cik":"0001179929","company_name":"MOLINA HEALTHCARE, INC.","filed_at":"2024-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.562690+00:00","generated_at":"2026-06-03T09:23:44.808944+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Molina Q1 GAAP EPS $5.17, adjusted $5.73; revenue rises to $9.93B; reaffirms FY2024 guidance","bullets":["Q1 GAAP EPS $5.17 vs $5.52 YoY; adjusted EPS $5.73 vs $5.81.","Total revenue $9.93B (+22% YoY) driven by premium revenue of $9.50B.","Medical care ratio 88.5%, up from 87.1% YoY; G&A ratio stable at 7.2%.","GAAP net income $301M vs $321M; adjusted net income $334M vs $337M.","Company reaffirms full-year 2024 revenue and earnings guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001179929-24-000086","json":"https://secwatch.observer/filing/0001179929-24-000086.json","markdown":"https://secwatch.observer/filing/0001179929-24-000086.md","text":"https://secwatch.observer/filing/0001179929-24-000086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1179929/000117992924000086/0001179929-24-000086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1179929/000117992924000086/moh-20240424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T09:23:44.808944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"04e8e727f889a023dff0d18abf1f9352245db489","claim":"MOLINA HEALTHCARE, INC. reported first quarter ended March 31, 2024 results: revenue Premium Revenue $9,504; Total Revenue $9,931, net income Net Income $334, EPS Adjusted EPS – Diluted $5.73. Guidance reaffirmed.","evidence_excerpt":"earnings per diluted share of $5.73. Financial results are summarized below: Three months ended March 31, 2024 2023 (In millions, except per-share results) Premium Revenue $9,504 $7,885 Total Revenue $9,931 $8,149 GAAP: Net Income $301 $321 EPS – Diluted $5.17 $5.52 Medical Care Ratio (MCR) 88.5 % 87.1 % G&A Ratio 7.2 % 7.2 % After-tax Margin 3.0 % 3.9 %","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992924000086/0001179929-24-000086-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"Premium Revenue $9,504; Total Revenue $9,931"},{"label":"Net income","value":"Net Income $334"},{"label":"EPS","value":"Adjusted EPS – Diluted $5.73"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}